3 hours Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $49.00 at Leerink PartnersMarketBeat
Leerink Partners raised their price target on shares of Mirum Pharmaceuticals from $47.00 to $49.00 and gave the company an “outperform” rating in a research report on Thursday.
Nasdaq 100 · Pharmaceuticals · Science
X